ইঙ্গিত ও ব্যবহার
1% ophthalmic preparation: As a cycloplegic or mydriatic for refraction or for desired dilatation of the iris or uveal tract during acute infammatory conditions.0.01% ophthalmic preparation: This medication is indicated as a treatment to slow the progression of myopia in children aged from 4 to 14 years. Mydri Mydri Atropine treatment may be initiated in children when myopia progresses.
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
প্রাপ্তবয়স্ক:
1% ophthalmic preparation- For uveitis: One drop three times daily For refraction: One drop in the eyes twice daily for one or two days before examination, and one hour before examination. Pressure should be maintained over lacrimal sac, occluding lacrimal duct for one minute after instillation. 0.01% ophthalmic preparation- This paediatric eye drops should be administered as one drop to each eye at night. The maximum benefit of treatment may not be achieved with less than a 2-year continued administration period. To minimize the risk of systemic absorption, gentle pressure should be applied to the tear duct for one minute after application.
পার্শ্বপ্রতিক্রিয়া
Blurred vision, local irritation, follicular conjunctivitis, vascular congestion, oedema, exudate, contact dermatitis, eczematous dermatitis, photophobia etc.
সতর্কতা ও নিষেধাজ্ঞা
সতর্কতা ও সাবধানতা
Mydri Mydri Atropine should not be used in children who have previously had severe systemic reaction to Mydri Mydri Atropine. An increased susceptibility to Mydri Mydri Atropine has been reported in children with Down’s syndrome, spastic paralysis, or brain damage; therefore Mydri Mydri Atropine should be used with great caution in these patients. It is recommended that regular eye health clinical reviews are conducted if long term treatment is planned, including the monitoring of anterior segment development, IOP, retinal health and myopia progression. This eye drops should not be used in children less than 4 years of age.
নিষেধাজ্ঞা
This eye drops is contraindicated in the presence of angle closure glaucoma or where angle closure glaucoma is suspected. If used in glaucoma susceptible patients, an estimation of the depth of the angle of the anterior chamber should be performed prior to the initiation of therapy.